Boc-Phe(4-NO2)-OHCAS# 33305-77-0 |
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- Z-VAD-FMK
Catalog No.:BCC1126
CAS No.:187389-52-2
- Z-WEHD-FMK
Catalog No.:BCC1139
CAS No.:210345-00-9
- Z-LEHD-FMK
Catalog No.:BCC5117
CAS No.:210345-04-3
- AZ 10417808
Catalog No.:BCC2356
CAS No.:331645-84-2
- Apoptosis Activator 2
Catalog No.:BCC2099
CAS No.:79183-19-0
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 33305-77-0 | SDF | Download SDF |
| PubChem ID | 118071 | Appearance | Powder |
| Formula | C14H18N2O6 | M.Wt | 310.3 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-nitrophenyl)propanoic acid | ||
| SMILES | CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)[N+](=O)[O-])C(=O)O | ||
| Standard InChIKey | XBQADBXCNQPHHY-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C14H18N2O6/c1-14(2,3)22-13(19)15-11(12(17)18)8-9-4-6-10(7-5-9)16(20)21/h4-7,11H,8H2,1-3H3,(H,15,19)(H,17,18) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Boc-Phe(4-NO2)-OH Dilution Calculator
Boc-Phe(4-NO2)-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2227 mL | 16.1134 mL | 32.2269 mL | 64.4538 mL | 80.5672 mL |
| 5 mM | 0.6445 mL | 3.2227 mL | 6.4454 mL | 12.8908 mL | 16.1134 mL |
| 10 mM | 0.3223 mL | 1.6113 mL | 3.2227 mL | 6.4454 mL | 8.0567 mL |
| 50 mM | 0.0645 mL | 0.3223 mL | 0.6445 mL | 1.2891 mL | 1.6113 mL |
| 100 mM | 0.0322 mL | 0.1611 mL | 0.3223 mL | 0.6445 mL | 0.8057 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Phe(4-NO2)-OH
- Dipsacoside B
Catalog No.:BCN5940
CAS No.:33289-85-9
- Gummiferin
Catalog No.:BCN8381
CAS No.:33286-30-5
- Diltiazem HCl
Catalog No.:BCC4901
CAS No.:33286-22-5
- 5,6-Dihydroyangonin
Catalog No.:BCN3566
CAS No.:3328-60-7
- 5-Aminofluorescein
Catalog No.:BCC8733
CAS No.:3326-34-9
- ML SA1
Catalog No.:BCC6276
CAS No.:332382-54-4
- Strychnistenolide
Catalog No.:BCN8039
CAS No.:332372-09-5
- 1,7-Bis(4-hydroxyphenyl)hepta-4,6-dien-3-one
Catalog No.:BCN7092
CAS No.:332371-82-1
- Rutaevin
Catalog No.:BCN6993
CAS No.:33237-37-5
- DZ2002
Catalog No.:BCC5544
CAS No.:33231-14-0
- Glucosyringic acid
Catalog No.:BCN5254
CAS No.:33228-65-8
- TCS 5861528
Catalog No.:BCC7816
CAS No.:332117-28-9
- NBD-557
Catalog No.:BCC1791
CAS No.:333352-59-3
- NBD-556
Catalog No.:BCC1790
CAS No.:333353-44-9
- Trianthenol
Catalog No.:BCN7802
CAS No.:333361-85-6
- Gliquidone
Catalog No.:BCC5003
CAS No.:33342-05-1
- Theaflavine-3,3'-digallate
Catalog No.:BCN5420
CAS No.:33377-72-9
- 9-O-Methyl-4-hydroxyboeravinone B
Catalog No.:BCN4063
CAS No.:333798-10-0
- Z-Asp(OtBu)-OSu
Catalog No.:BCC2787
CAS No.:3338-32-7
- 8-Deoxygartanin
Catalog No.:BCN5255
CAS No.:33390-41-9
- Gartanin
Catalog No.:BCN5256
CAS No.:33390-42-0
- LUF 5834
Catalog No.:BCC6237
CAS No.:333962-91-7
- (E)-2-Decenoic acid
Catalog No.:BCC1292
CAS No.:334-49-6
- Spermidine trihydrochloride
Catalog No.:BCC6865
CAS No.:334-50-9
Plant peptide hormone phytosulfokine (PSK-alpha): synthesis of new analogues and their biological evaluation.[Pubmed:15298181]
J Pept Sci. 2004 Jul;10(7):462-9.
Phytosulfokine-alpha (PSK-alpha), a sulfated growth factor (H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln-OH) universally found in both monocotyledons and dicotyledons, strongly promotes proliferation of plant cells in culture. In our studies on structure/activity relationship in PSK-alpha the synthesis of a series of analogues was performed: [H-D-Tyr(SO3H)1]- (9), [H-Phe(4-SO3H)1]- (10), [H-D-Phe(4-SO3H)1]- (11), [H-Phg(4-SO3H)1]- (12), [H-D-Phg(4-SO3H)1]- (13), H-Phe(4-NHSO2CH3)1]- (14), [H-D-Phe(4-NHSO2CH3)1]- (15), [H-Phe(4-NO2)1]- (16), [H-D-Phe(4-NO2)1]- (17), [H-Phg(4-NO2)1]- (18), [H-D-Phg(4-NO2)1]- (19), [H-Hph(4-NO2)1]- (20), [H-Phg(4-OSO3H)1]- (21), [Phe(4-NO2)3]- (22), [Phg(4-NO2)3]- (23), [Hph(4-NO2)3]- (24), [H-Phe(4-SO3H)1, Phe(4-SO3H)3]- (25) [H-Phe(4-NO2)1, Phe(4-NO2)3]- (26), [H-Phg(4-NO2)1, Phg(4-NO2)3]- (27), [H-Hph(4-NO2)1, Hph(4-NO2)3]- (28) and [Val3]- PSK-alpha (29). For modification of the PSK-alpha peptide chain the novel amino acids and their derivatives were synthesized, such as: H-L-Phg(4-SO3H)-OH (1), H-D-Phg(4-SO3H)-OH (2), Fmoc-Phg(4-SO3H)-OH (3), Fmoc-D-Phg(4-SO3H)-OH (4), Boc-Phg(4-NHSO2CH3)-OH (5), Boc-D-Phg(4-NHSO2CH3)-OH (6) Boc-Phe(4-NHSO2CH3)-OH (7), and Boc-D-Phe(4-NHSO2CH3)-OH (8). Peptides were synthesized by a solid phase method according to the Fmoc procedure on a Wang-resin. Free peptides were released from the resin by 95% TFA in the presence of EDT. All peptides were tested by competitive binding assay to the carrot membrane using 3H-labelled PSK according to the Matsubayashi et al. test.
